BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35763909)

  • 21. Leptin modulates dose-dependently the metabolic and cytolytic activities of NK-92 cells.
    Lamas B; Goncalves-Mendes N; Nachat-Kappes R; Rossary A; Caldefie-Chezet F; Vasson MP; Farges MC
    J Cell Physiol; 2013 Jun; 228(6):1202-9. PubMed ID: 23129404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Photophosphatidylserine Guides Natural Killer Cell Photoimmunotherapy
    Yang X; Li M; Qin X; Tan S; Du L; Ma C; Li M
    J Am Chem Soc; 2022 Mar; 144(9):3863-3874. PubMed ID: 35226805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-155 regulates interferon-γ production in natural killer cells via Tim-3 signalling in chronic hepatitis C virus infection.
    Cheng YQ; Ren JP; Zhao J; Wang JM; Zhou Y; Li GY; Moorman JP; Yao ZQ
    Immunology; 2015 Aug; 145(4):485-97. PubMed ID: 25772938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The functional potency of natural killer cells in response to IL-2/IL-15/IL-21 stimulation is limited by a concurrent upregulation of Tim-3 in bladder cancer.
    Zhang W; Feng H; Chen Q; Lu X; Ge J
    Exp Cell Res; 2018 Nov; 372(2):92-98. PubMed ID: 30243902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Natural killer cells contribute to hepatic injury and help in viral persistence during progression of hepatitis B e-antigen-negative chronic hepatitis B virus infection.
    Ghosh S; Nandi M; Pal S; Mukhopadhyay D; Chakraborty BC; Khatun M; Bhowmick D; Mondal RK; Das S; Das K; Ghosh R; Banerjee S; Santra A; Chatterjee M; Chowdhury A; Datta S
    Clin Microbiol Infect; 2016 Aug; 22(8):733.e9-733.e19. PubMed ID: 27208430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipid accumulation impairs natural killer cell cytotoxicity and tumor control in the postoperative period.
    Niavarani SR; Lawson C; Bakos O; Boudaud M; Batenchuk C; Rouleau S; Tai LH
    BMC Cancer; 2019 Aug; 19(1):823. PubMed ID: 31429730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tim-3 Blockade Elicits Potent Anti-Multiple Myeloma Immunity of Natural Killer Cells.
    Jiang W; Li F; Jiang Y; Li S; Liu X; Xu Y; Li B; Feng X; Zheng C
    Front Oncol; 2022; 12():739976. PubMed ID: 35280800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is IFN expression by NK cells a hallmark of severe COVID-19?
    Csordas BG; de Sousa Palmeira PH; Peixoto RF; Comberlang FCQDDS; de Medeiros IA; Azevedo FLAA; Veras RC; Janebro DI; Amaral IPG; Barbosa-Filho JM; Keesen TSL
    Cytokine; 2022 Sep; 157():155971. PubMed ID: 35908408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The breast tumor microenvironment alters the phenotype and function of natural killer cells.
    Krneta T; Gillgrass A; Chew M; Ashkar AA
    Cell Mol Immunol; 2016 Sep; 13(5):628-39. PubMed ID: 26277898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Galectin-9/Tim-3 pathway is involved in the regulation of NK cell function at the maternal-fetal interface in early pregnancy.
    Li YH; Zhou WH; Tao Y; Wang SC; Jiang YL; Zhang D; Piao HL; Fu Q; Li DJ; Du MR
    Cell Mol Immunol; 2016 Jan; 13(1):73-81. PubMed ID: 25578313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of CXCR1 and CXCR3 expression on NK cells via Tim-3 in a murine model of primary biliary cholangitis.
    Xu J; Fu H; Yang Y; Yu H; Ai X; Lei Y; Bao W; Tang Y
    Mol Immunol; 2021 Jul; 135():342-350. PubMed ID: 33984607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetically re-engineered K562 cells significantly expand and functionally activate cord blood natural killer cells: Potential for adoptive cellular immunotherapy.
    Ayello J; Hochberg J; Flower A; Chu Y; Baxi LV; Quish W; van de Ven C; Cairo MS
    Exp Hematol; 2017 Feb; 46():38-47. PubMed ID: 27765614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased Tim-3 expression in peripheral NK cells predicts a poorer prognosis and Tim-3 blockade improves NK cell-mediated cytotoxicity in human lung adenocarcinoma.
    Xu L; Huang Y; Tan L; Yu W; Chen D; Lu C; He J; Wu G; Liu X; Zhang Y
    Int Immunopharmacol; 2015 Dec; 29(2):635-641. PubMed ID: 26428847
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kctd9 Deficiency Impairs Natural Killer Cell Development and Effector Function.
    Zhang X; Wang P; Chen T; Yan W; Guan X; Shen G; Luo X; Wan X; Ning Q
    Front Immunol; 2019; 10():744. PubMed ID: 31024568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma Gelsolin Inhibits Natural Killer Cell Function and Confers Chemoresistance in Epithelial Ovarian Cancer.
    Onuma T; Asare-Werehene M; Fujita Y; Yoshida Y; Tsang BK
    Cells; 2024 May; 13(11):. PubMed ID: 38891037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid development of exhaustion and down-regulation of eomesodermin limit the antitumor activity of adoptively transferred murine natural killer cells.
    Gill S; Vasey AE; De Souza A; Baker J; Smith AT; Kohrt HE; Florek M; Gibbs KD; Tate K; Ritchie DS; Negrin RS
    Blood; 2012 Jun; 119(24):5758-68. PubMed ID: 22544698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro analysis of the proliferative capacity and cytotoxic effects of ex vivo induced natural killer cells, cytokine-induced killer cells, and gamma-delta T cells.
    Niu C; Jin H; Li M; Xu J; Xu D; Hu J; He H; Li W; Cui J
    BMC Immunol; 2015 Oct; 16():61. PubMed ID: 26458364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NK cell-based therapeutics for lung cancer.
    Pockley AG; Vaupel P; Multhoff G
    Expert Opin Biol Ther; 2020 Jan; 20(1):23-33. PubMed ID: 31714156
    [No Abstract]   [Full Text] [Related]  

  • 39. Hepatic natural killer cells exclusively kill splenic/blood natural killer-resistant tumor cells by the perforin/granzyme pathway.
    Vermijlen D; Luo D; Froelich CJ; Medema JP; Kummer JA; Willems E; Braet F; Wisse E
    J Leukoc Biol; 2002 Oct; 72(4):668-76. PubMed ID: 12377935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperthermia suppresses the cytotoxicity of NK cells via down-regulation of perforin/granzyme B expression.
    Koga T; Harada H; Shi TS; Okada S; Suico MA; Shuto T; Kai H
    Biochem Biophys Res Commun; 2005 Dec; 337(4):1319-23. PubMed ID: 16236268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.